Keywords: Strides Arcolab, Onco Therapies, Pfizer, Carboplatin, Oxaliplating, USA, FDA

Strides Arcolab gets two more cancer generics approved in USA

Article | 27 November 2011

Print This

Onco Therapies, a wholly owned subsidiary of Indian generics drugmakers Strides Arcolab (BO: 532531), has received approvals from the US Food ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in